Skip to content

CHINA PEDIATRIC PHARMACEUTICALS, INC.: 10-Q filed 2013-11-19

What CHINA PEDIATRIC PHARMACEUTICALS, INC. reported in its quarterly report filed 2013-11-19 (fiscal Q3 2013): 32 published measures, 87 facts as tagged in accession 0001017386-13-000285.

This filing

Form
10-Q (quarterly report)
Filed
2013-11-19
Fiscal period
fiscal Q3 2013
Accession
0001017386-13-000285 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA PEDIATRIC PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-09-306,747,902USD
At 2012-12-3112,119,512USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-09-305,664,222USD
At 2012-12-3111,619,464USD
At 2011-12-3120,597,650USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-09-302,163,082USD
At 2012-12-311,102,349USD
At 2012-09-30987,440USD
At 2011-12-312,186,650USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-269,562USD92
2013-01-01 to 2013-09-30-6,192,742USD273
2012-01-01 to 2012-12-31-9,152,318USD366
2012-07-01 to 2012-09-30-3,580,461USD92
2012-01-01 to 2012-09-30-5,818,013USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-09-301,079,992USD273
2012-01-01 to 2012-09-30-530,277USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-60,983USD273
2012-01-01 to 2012-09-30-681,557USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-09-30743,359USD
At 2012-12-31791,405USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-09-3015,625USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-269,559USD92
2013-01-01 to 2013-09-30-6,192,731USD273
2012-07-01 to 2012-09-30-3,580,429USD92
2012-01-01 to 2012-09-30-5,817,846USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-09-304,731,444USD
At 2012-12-319,881,061USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-09-301,083,680USD
At 2012-12-31500,048USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-09-3010,112USD
At 2012-12-3184,373USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-09-301,910,322USD
At 2012-12-314,673,315USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-09-3081,535USD
At 2012-12-31472,274USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-30257,764USD92
2013-01-01 to 2013-09-30949,753USD273
2012-07-01 to 2012-09-30978,954USD92
2012-01-01 to 2012-09-305,060,695USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2013-07-01 to 2013-09-30104,162USD92
2013-01-01 to 2013-09-30349,342USD273
2012-07-01 to 2012-09-30217,442USD92
2012-01-01 to 2012-09-302,062,393USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-07-01 to 2013-09-30299,019USD92
2013-01-01 to 2013-09-301,177,992USD273
2012-07-01 to 2012-09-30711,332USD92
2012-01-01 to 2012-09-302,868,158USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-09-3044,556,104shares
At 2012-12-3144,556,104shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-09-3014,102,507USD
At 2012-12-3114,102,507USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-09-303,434,265USD
At 2012-12-313,196,765USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-09-301,779,079USD
At 2012-12-311,732,633USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-09-301,035,720USD
At 2012-12-31941,228USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-09-301,273,099USD
At 2012-12-311,447,046USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-269,562USD92
2013-01-01 to 2013-09-30-6,192,742USD273
2012-07-01 to 2012-09-30-3,580,461USD92
2012-01-01 to 2012-09-30-5,818,013USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-212,134USD92
2013-01-01 to 2013-09-30-5,955,242USD273
2012-07-01 to 2012-09-30-3,612,728USD92
2012-01-01 to 2012-09-30-5,706,095USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-07-01 to 2013-09-3022,500USD92
2013-01-01 to 2013-09-3068,443USD273
2012-07-01 to 2012-09-3022,902USD92
2012-01-01 to 2012-09-3069,524USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-09-30278,670USD273
2012-01-01 to 2012-09-30276,400USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2013-07-01 to 2013-09-3070,076USD92
2013-01-01 to 2013-09-30210,227USD273
2012-07-01 to 2012-09-3068,875USD92
2012-01-01 to 2012-09-30206,878USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-3USD92
2013-01-01 to 2013-09-30-11USD273
2012-07-01 to 2012-09-30-32USD92
2012-01-01 to 2012-09-30-167USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-3061,533USD273
2012-01-01 to 2012-09-30-1,112,751USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30398,637USD273
2012-01-01 to 2012-09-30-484,738USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-75,619USD273
2012-01-01 to 2012-09-30-282,924USD274

Inspect the source

Entity
CHINA PEDIATRIC PHARMACEUTICALS, INC. / CIK 0001354071
Captured
SEC response SHA-256
9fa973e7cfeb332db52412b0c379de3e69dd9dc277445b38b119cd4940a59804

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001354071.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))